Mental Health and Academic Performance in COVID-19

Depression, Anxiety Clinical Trial

— PANDEMIC  

Official title:

dePression, Anxiety, aNd acaDemic pErforMance In Covid-19: PANDEMIC Study.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04420416
• Other study ID #: Mental01
• Status: Completed
• Start date: April 1, 2020
• Est. completion date: July 30, 2020

Study information

• Verified date: September 2023
• Source: Instituto Mexicano del Seguro Social
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to identify the preference of the class modalities (classroom or online) in undergraduate and graduate students. Additionally, to explore if the presence of any mental state alterations such as depression or anxiety due to the COVID-19 pandemic can alter their perception of academic performance.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 720
• Est. completion date: July 30, 2020
• Est. primary completion date: July 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• > 18 years
• Students of any undergraduate or graduate course who are attending their semester online

Exclusion Criteria:

• Students who are not attending an online course
• Students who are not registered in a university undergraduate or graduate course.

Related Conditions & MeSH terms

• Anxiety Disorders
• COVID-19
• Depression
• Depression, Anxiety
• Depressive Disorder

Intervention

Other:
• Survey
The investigators will use the Spanish language validated version of the Academic Self-Concept Scale (ASCS), the Patient Health Questionnaire-9 (PHQ-9) depression screening scale, and the General Anxiety Disorder-7 (GAD-7) screening scale. Additionally, the sample will be asked about their gender, age, preference of teaching modality, and finally, if the participants have perceived a change in their performance or any change in their grades.

Locations

Country	Name	City	State
Mexico	Instituto Mexicano del Seguro Social	Guadalajara	Jalisco

Sponsors (1)

Lead Sponsor	Collaborator
Instituto Mexicano del Seguro Social

Country where clinical trial is conducted

Mexico, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Academic Self-Concept Scale Score	This scale will explore the effort and confidence of the participants. The minimum score for each facet is 10, and the maximum score is 70.	up to 3 months
Primary	PHQ-9 Score	This inventory will be used to identify the presence and intensity of depressive disorders. The minimum score is 0, and the maximum score is 27.	up to 3 months
Primary	GAD-7 Score	This questionnaire will be used to evaluate the presence and intensity of anxiety disorders. The minimum score is 0, and the maximum score is 21.	up to 3 months
Primary	Preference of teaching method	Students' preference of classroom or online classes.	up to 3 months
Primary	Self perceived academic performance	Students' perception of changes in their academic performance: got better, worse, or stayed the same.	up to 3 months
Primary	Academic grades changes	Students' perception of changes in their grades: got better, worse, or stayed the same.	up to 3 months